Back to Program
Back to Summit

Shaping the Future of U.S. Pharma Manufacturing in a Changing Regulatory Landscape

American Pharma Manufacturing & Outsourcing Summit 2025
  • Exploring strategies for reshoring production to enhance supply chain resilience and efficiency
  • Evaluating incentives and policies driving adoption of advanced manufacturing technologies
  • Addressing regulatory changes while maintaining compliance and operational excellence across operations
  • Leveraging domestic production trends to reduce global risk and strengthen industry competitiveness
Image
Andy Ramelmeier, Ph.D.
Chief Technology Officer
Adverum Biotechnologies
Image
Amlan Dutta, Ph.D.
Head, Quality, Rare Disease, Oncology, and Immunology
Sanofi
Image
Lori Canzanese
Executive Director, Digital Manufacturing Operations
Merck
Image
Colin Baker
SVP, Quality Assurance
Bimeda
Image
Cedric Dubois
SVP, Head of Global External Manufacturing
Teva Pharmaceuticals
Laks Pernenkil, Ph.D.
Principal, Life Sciences Product, Supply and Manufacturing Operations Practice Leader
Deloitte